Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer
Status:
Withdrawn
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
Single compassionate use subject is an 83 year old woman with a history of lymph node
positive breast cancer and recently diagnosed pancreatic cancer in May. With an Eastern
Cooperative Oncology Group (ECOG) of 2, it is felt that she cannot tolerate more aggressive
chemotherapy. The investigators propose to administer FG-3019 on a compassionate pleas basis
in combination with gemzar. The patient is currently being treated and is tolerating gemzar.